Cancer Innovation2025，Vol.4Issue(6)：P.151-164,14.DOI:10.1002/cai2.70036
Identification of Chondroitin Polymerizing Factor as a Biomarker for Colorectal Cancer by the Human Villi Development Model
Botao Zhang 1Yuanjing Wang 2Rongfang Shen 3Hongxia Li 4Wenbin Li 5Lin Feng 3Shujun Cheng3
作者信息
- 1. Department of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,China State Key Laboratory of Molecular Oncology,Department of Etiology and Carcinogenesis,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
- 2. Department of Gynecological Oncology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing,China Beijing Maternal and Child Health Care Hospital,Capital Medical University,Beijing,China
- 3. State Key Laboratory of Molecular Oncology,Department of Etiology and Carcinogenesis,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
- 4. Department of Obstetrics and Gynecology,Beijing Shijitan Hospital,Capital Medical University,Beijing,China
- 5. Department of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,China
- 折叠
摘要
关键词
chondroitin polymerizing factor/colorectal cancer/gene interactions/prognosis/villi分类
医药卫生引用本文复制引用
Botao Zhang,Yuanjing Wang,Rongfang Shen,Hongxia Li,Wenbin Li,Lin Feng,Shujun Cheng..Identification of Chondroitin Polymerizing Factor as a Biomarker for Colorectal Cancer by the Human Villi Development Model[J].Cancer Innovation,2025,4(6):P.151-164,14.基金项目
supported by the CAMS Innovation Fund for Medical Sciences(CIFMS2016-I2M-3-005) （CIFMS2016-I2M-3-005）
the National and Provincial Clinical Key Specialty Capacity Building Project of 2020(No.2-1-2-038). （No.2-1-2-038）
